Senior Immunogenicity Scientist
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
The department of Clinical Immunogenicity Analysis is seeking an experienced and motivated Senior Immunogenicity Scientist to be responsible for assessment of immunogenicity in clinical human trials as well as non-clinical animal studies. Experience with bioanalysis and/or biomarker assessment is appreciated but not required. Do you see yourself in this role? Then this might be the right opportunity for you. About the Department The Clinical Immunogenicity Analysis department is responsible for assessment of immunogenicity, primarily induction of anti-drug antibodies, of pharmaceutical drugs within the Novo Nordisk A/S portfolio. We develop and validate assays for detection and characterization of antibody responses to drug candidates according to relevant white papers and regulatory guidelines. Our area Non-clinical and Clinical Assay Sciences (NCAS) is responsible for pre-clinical and clinical bioanalysis of pharmaceutical drugs, covering pharmacokinetic, immunogenicity and biomarker analyses. We support the entire drug product portfolio of Novo Nordisk A/S. NCAS consists of five departments with a strong collaborative atmosphere and shared laboratory facilities that house a range of different state-of-the art techniques, e.g. different ligand-binding assays such as ELISA, MSD, AlphaLISA, RIA, Gyros, SPR, LCMS as well as cell-based assays. NCAS is a GLP/GCP regulated area and is currently undergoing a transformation towards more digitized and automated laboratory processes. Our area is part of Global Discovery & Development Sciences and we are located in Måløv (greater Copenhagen). The Position The current position is located in the Clinical Immunogenicity Analysis department, which consists of 16 highly skilled scientists and technicians. As Senior scientist in our department you will be part of both non-clinical and clinical project groups with stakeholders from different parts of Novo Nordisk. You will be responsible for immunogenicity assessment strategy, development and validation of new assays (e.g. RIA, MSD, ELISA and cell based assays) in close collaboration with technicians, analysis of samples from non-clinical and clinical studies in compliance with GLP and GCP requirements and regulatory guidelines and eventually outsourcing of the assays to Contract Laboratories. You will join an area that is undergoing an exciting transformation and can look forward to a very interesting and challenging position in an international and scientifically strong environment. Qualifications You hold a MSc / Ph.D. in immunology (or other relevant area), alternatively you have extensive industry experience, preferably within drug development. A candidate with strong theoretical and hands-on knowledge on antibody assays will be preferred. A ‘high level of quality’ mindset is essential as we work according to regulatory guidelines and quality systems. You have excellent communication skills and are a dedicated team player that like to have fun at work and enjoy belonging to a good and high-performing team. You have a good sense of humour and are a result-oriented, flexible and a dedicated team player. You enjoy handling different types of tasks at the same time. You have interpersonal skills that allow you to build fruitful relations to both colleagues and stakeholders and have excellent English communication skills, both written and oral. NCAS has a strong collaborative atmosphere and experience within bioanalysis, biomarkers or laboratory automation and digitalization are welcome but not a requirement for the current position. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive change. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. Working at Novo Nordisk is working toward something bigger than ourselves, and it’s a collective effort. Novo Nordisk relies on the joint potential and collaboration of its more than 40,000 employees to change the lives for the better for millions of patients living with diabetes and other chronic diseases. Together, we go further. Together, we’re life changing. Contact For further information, please contact Mari Enoksson, Department Manager Clinical Immunogenicity Analysis at + 45 3079 2113. Deadline 29 January 2023 . Applications will be reviewed on an on-going basis. You do not need to attach a cover letter to your application but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 10.1.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Måløv
Lignende jobs
-
(Senior) IT Analyst, Application Maintenance area
Job ID: 21220 We are looking for a SWIFT IT Analyst who is self-driven, communicative, with good understanding of critical enterprise environments and importance of operational stability to rai..- Forretningsudvikler
- Taastrup
-
Business Developer with passion for process automa...
Job ID: 26825 Are you passionate about and have flair for process optimization through coding? And do you get top motivated by the thought of creating and driving the digital agenda? Then you may..- Forretningsudvikler
- København S
-
Clinical Publisher
Are you a fast learner and interested in clinical development and documentation? Do you have a quality mindset and a flair for learning new software? We are now looking for a Clinical Publisher for..- Forretningsudvikler
- Søborg
-
Project Manager, Lystrup or Søborg
[xxxxx] is facing an exciting future with considerable growth and demanding changes, as we deliver advanced technologies and mission critical solutions for the defense and aerospace industry. Our s..- Forretningsudvikler
- Søborg
Statistik over udbudte jobs som forretningsudviklere i Måløv
Herunder ser du udviklingen i udbudte forretningsudvikler i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Måløv over tid
Dato | Alle jobs som forretningsudviklere |
---|---|
4. november 2024 | 1 |
3. november 2024 | 3 |
2. november 2024 | 3 |
1. november 2024 | 3 |
31. oktober 2024 | 4 |
30. oktober 2024 | 4 |
29. oktober 2024 | 4 |
28. oktober 2024 | 4 |
27. oktober 2024 | 6 |
26. oktober 2024 | 6 |
25. oktober 2024 | 7 |
24. oktober 2024 | 7 |
23. oktober 2024 | 7 |
22. oktober 2024 | 8 |
21. oktober 2024 | 9 |
20. oktober 2024 | 12 |
19. oktober 2024 | 12 |
18. oktober 2024 | 11 |
17. oktober 2024 | 10 |
16. oktober 2024 | 10 |
15. oktober 2024 | 10 |
14. oktober 2024 | 10 |
13. oktober 2024 | 13 |
12. oktober 2024 | 13 |
11. oktober 2024 | 13 |
10. oktober 2024 | 12 |
9. oktober 2024 | 13 |
8. oktober 2024 | 12 |
7. oktober 2024 | 12 |
6. oktober 2024 | 15 |
5. oktober 2024 | 15 |